A strategy targeting ferroptosis for mitochondrial reprogramming and intervertebral disc degeneration therapy
Theranostics · 2025
DOI: 10.7150/thno.117725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Tianyi Wu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, China. Hauptthemen laut MEDLINE: Ferroptosis, Intervertebral Disc Degeneration, Mitochondria, Deferoxamine. Die Arbeit wurde bisher 19-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, China.
- Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou, Jiangsu, China.
Zitieren
APA
Wu, T., Teng, Y., Song, D., Yang, Y., Shen, H., Sun, X., Chen, R., Zhao, L., Zhong, X., Yan, Q., Niu, J., Ge, J., Cheng, L., & Zou, J. (2025). A strategy targeting ferroptosis for mitochondrial reprogramming and intervertebral disc degeneration therapy. Theranostics. https://doi.org/10.7150/thno.117725
Vancouver
Wu T, Teng Y, Song D, Yang Y, Shen H, Sun X, et al. A strategy targeting ferroptosis for mitochondrial reprogramming and intervertebral disc degeneration therapy. Theranostics. 2025. doi:10.7150/thno.117725
BibTeX
@article{Wu2025,
author = {Wu, Tianyi and Teng, Yun and Song, Dawei and Yang, Yuqi and Shen, Huaishuang and Sun, Xiao and Chen, Rui and Zhao, Leyu and Zhong, Xianggu and Yan, Qi and Niu, Junjie and Ge, Jun and Cheng, Liang and Zou, Jun},
title = {A strategy targeting ferroptosis for mitochondrial reprogramming and intervertebral disc degeneration therapy},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.117725}
}
EUVIMED